Farooq A. Bandali, PharmD, BCPS CURRENT POSITIONS Clinical Assistant Professor Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey 160 Frelinghuysen Road, Room 417A Piscataway, NJ 08854 (o): 732-745-8600 ext 5742 (f): 732-626-6291 fbandali@rci.rutgers.edu Critical Care Clinical Pharmacist Saint Peter s University Hospital (SPUH) Department of Pharmaceutical Services 254 Easton Avenue New Brunswick, NJ 08901 (o): 732-745-8600 ext 5742 (f): 732-626-6291 fbandali@saintpetersuh.com EDUCATION AND TRAINING 2005-2006 Critical Care Pharmacy Residency; Medical University South Carolina; Charleston, South Carolina 2004 2005 Pharmacy Practice Residency; Charleston Area Medical Center, Charleston, West Virginia 1994 2000 Doctor of Pharmacy Degree; University of Texas at Austin, College of Pharmacy, Austin, Texas LICENSURE 2006 New Jersey (Active) 2001 Connecticut (Active) 2001 Texas (Active) CERTIFICATIONS 2008 Mini-MBA Program: Strategic Healthcare Management Program jointly sponsored by Rutgers, The State University of New Jersey and Saint Peter s University Hospital 2007 Board Certified Pharmacotherapy Specialist 2006 Academician Preparation (Teaching Certificate) Program, South Carolina College of Pharmacy
Farooq Bandali Curriculum Vitae Page 2 PROFESSIONAL EXPERIENCES 2003-2004 Pharmacy Technician Program Lecturer Norwalk Community College Norwalk, Connecticut 2002-2004 Staff/Clinical Pharmacist Bridgeport Hospital Bridgeport, Connecticut 2001-2002 Staff Pharmacist CVS Pharmacy Fairfield, Connecticut TEACHING EXPERIENCES Clinical Assistant Professor Department of Pharmacy Practice and Administration Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, NJ Clinical Preceptor Advanced Pharmacy Practice Experience for Doctor of Pharmacy students in the Medical/Surgical Intensive Care Unit (ICU) at Saint Peter s University Hospital. Precept 16-18 students per year Didactic Teaching Critical Care Pharmacotherapy (31:725:582:01) Course Co-coordinator (2008-Present) Cardiogenic Shock (2011-Present) Neurocritical Care: Stroke and Traumatic Brain Injury (2011) Severe Sepsis & Neurogenic Shock: Learning through simulation (2011) Severe Sepsis & Ischemic Stroke: Learning through simulation (2012) Interpreting Arterial Blood Gases (ABG) (2010-Present) Common infections in the ICU I (2010-Present) Common infections in the ICU II (2010-Present) Introduction to Critical Care (2010, 2012) Therapeutic Drug Monitoring (2010) Shock syndromes (2008-2011) Shock I: Basic concepts and vasoactive agent overview (2012-Present)
Farooq Bandali Curriculum Vitae Page 3 TEACHING EXPERIENCES (continued) Shock II: Cardiogenic and Hypovolemic Shock (2012-Present) Shock III: Distributive Shock Focus on Sepsis (2012-Present) Sedatives, analgesics & neuromuscular blockers (2007, 2008, 2010) Clinical management of sepsis (2007-Present) Delirium in the ICU (2007, 2008, 2009) Interactive Sessions (2008, 2009, 2012, 2013) Cardiopulmonary Therapeutics (30:725:460) Shock Syndromes (2007-Present) Advanced Pharmacotherapy Applications (31:725:579:01) Massive Pulmonary Embolism (2011, 2013) Severe Sepsis & Acute Coronary Syndrome: Learning via simulation (2010) Acute Coronary Syndrome and Cardiogenic Shock (2009) Heparin-induced thrombocytopenia (2008) 2005-Present Lecturer University of Florida, College of Pharmacy Working Professional PharmD Program (WPPD) Gainesville, Florida Women s Health and Endocrine & Hematologic Disorders (PHA5594) Managing Hyperglycemic Crisis in Diabetes (2007, 2010) Thyroid disease (2007, 2010) Circulatory Disorders (PHA5591) Managing Hypertensive Crisis (2006, 2007, 2009) Neurological and Psychiatric Disorders (PHA5598) Traumatic Brain Injury (2005) Meningitis (2005) CLINICAL PRACTICE Critical Care Clinical Pharmacist Saint Peter s University Hospital Department of Pharmaceutical Services New Brunswick, New Jersey Clinical duties include rounding with a multidisciplinary team, responding to code blue and code stroke calls, assisting the intensive care unit team to admit patients from the emergency room to the ICU, helping to establish clinical pharmacy services within the ICU setting with an emphasis on drug utilization, provision of drug information to healthcare professionals, and delivering educational presentations for nursing, pharmacy and medical staff.
Farooq Bandali Curriculum Vitae Page 4 CLINICAL PRACTICE (continued) Institution-wide Committee Involvement [extension of clinical practice] Chair, Antibiotic Subcommittee (Jan 2009-Present). In 2010, conducted a pilot antimicrobial stewardship program (ASP) in the ICU. Due to the success of the pilot program, a hospital-wide ASP was established in 2012. Chair, Anticoagulation Committee (Jan 2009- Present). Developed order sets, guidelines and policies to help with patient safety initiatives. These include argatroban, enoxaparin, heparin and warfarin order sets. Additional Order Sets/Guidelines/Policies/Medication Use Evaluation Developed (or assisted with) at SPUH Alteplase for Catheter-Directed Thrombolysis, Antibiogram reporting CRRT Order Set Ertapenem Medication Use Evaluation Heparin Medication Use Evaluation Intravenous Acetaminophen Medication Use Evaluation Pneumonia Order Set Sedation Order Set Severe Sepsis Order Set Surgical Care Infection Prevention (SCIP) Order Set Total Parenteral Nutrition Order Set Vancomycin Order Set Vasoactive Order Set Other Institution and ICU Committee Involvement [extension of clinical practice] Pneumonia Rapid Cycle Task Force (2010 Present) New Jersey Hospital Association (NJHA) Surviving Sepsis Campaign Committee (2008 Present) Critical Care Committee (2006 Present) Pharmacy and Therapeutics Committee (2006 Present) PRESENTATIONS National Presentations 2012 Bandali FA, Thomas Z, Sankaranarayan, J Reardon T, Olsen K. Prevalence and Factors Associated With Prolonged Surgical Prophylaxis: Analysis from the Prolonged Empiric Antibiotic Therapy Study presented at 42 nd Annual Congress for the Society of Critical Care Medicine (SCCM) Annual Congress in Houston, Texas
Farooq Bandali Curriculum Vitae Page 5 PRESENTATIONS (continued) 2012 Thomas Z, Bandali FA, Sankaranarayan, J Reardon T, Olsen K. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult Intensive Care Units in the United States presented at 42 nd Annual Congress for the Society of Critical Care Medicine Annual Congress in Houston, Texas 2009 Neuropharmacology: Therapeutic Controversies in 2009 presented at the American Academy of Critical Care Nurses Annual Meeting held in New Orleans, LA 2009 Barbarello-Andrews L, Bandali FA, Pfeiffer CM. Assessment of Outcomes of a Unique Critical Care Elective Course presented at the 2009 Annual Meeting for the American Association of Colleges of Pharmacy in Boston, MA 2008 Recombinant Factor VIIa in Acute Intracerebral Haemorrhage (FAST) Trial presented at the National Mayo Clinic Journal Club (Teleconference) Regional Presentations 2012 Emerging anticoagulants in atrial fibrillation: Will warfarin become the thing of the past? Presented to pharmacists for Rutgers Anticoagulation Continuing Education (CE) Seminar 2011 Managing Gram Negative Infections: Past, Present and Future Presented to pharmacists for Rutgers Infectious Disease CE Seminar 2011 Multi-Drug Resistance: What a Dilemma! Presented to pharmacists for Rutgers Infectious Disease CE Seminar 2010 Management of Intracerebral and Subarachnoid hemorrhage Presented to pharmacists for Rutgers Stroke CE Seminar 2010 Proton Pump Inhibitors: The Good, The Bad & The Controversial Presented to pharmacists for Rutgers CE Seminar 2009 Managing Type II Diabetes: In Search Of A New Paradigm Presented to pharmacists at Sanofi-Aventis, Bridgewater, New Jersey for Rutgers Diabetes CE seminar 2009 Inpatient Management of Venous Thromboembolism Presented to pharmacist for the Roy Bowers CE Seminar 2008 The Role of the Clinical Pharmacist in the Hospital Setting Presented at Kean University to students in the Masters of Science, Technology & Mathematics Education program 2008 Striking Back at HIT: What a pharmacist should know? Presented to pharmacists for the Rutgers Cardiology CE Seminar
Farooq Bandali Curriculum Vitae Page 6 PRESENTATIONS (continued) 2008 Managing Pneumonia: What A Clinical Enigma Presented to Rutgers Infectious Disease CE Seminar 2008 Glitazones and Cardiotoxicity: Pandora s Box has been opened! Presented to pharmacists and pharmacy students for Rutgers Cardiology CE Seminar 2007 Striking Back at HIT: What a pharmacist should know? Presented to pharmacists for Rutgers Cardiology CE Seminar SPUH Medical, Surgical and Nursing Grand Rounds Seminar 2013 Inpatient Management of Venous Thromboembolism (VTE) 2013 Hypertension & Stroke: The Role of the Nurse 2013 Antimicrobial Stewardship: Achieving Success Through A Collaborative Approach 2012 Emerging anticoagulants in atrial fibrillation: Pearls for the Beside Practitioner 2010 TPA & BP Management in Acute Ischemic Stroke (AIS): The Role of The Nurse 2010 2009 Pressure Ulcers in the ICU: A Critical Dilemma 2009 Critical Care: Therapeutic Controversies in 2009 2007 Recombinant Factor VIIa (rfviia) in Postpartum hemorrhage (PPH): Evidencebase or experience-base medicine? 2007 Brain bleed secondary to rat poison : Is PCC or rfviia the magical antidote? SPUH Institutional Presentations to Physicians, Pharmacists and Nurses 2012 Emerging anticoagulants in atrial fibrillation: Pearls for the Practitioner 2012 Antimicrobial Stewardship Program: What is the opportunity at SPUH? 2012 Dexmedetomidine (Precedex ): Finding Where It Fits 2012 Shock Syndromes 2010 Striking back at Heparin induced thrombocytopenia (HIT): A Therapeutic Update 2010 Shock Syndromes 2010 Clinical Application of Vancomycin and SPUH Guidelines 2009 Sedation, Analgesia & Neuromuscular Blockers 2009 Striking back at Heparin-Induced thrombocytopenia (HIT): A Therapeutic Update 2009 Shock Syndromes 2008 The Role of Acid Suppression in the Hospitalized Patients 2008 Striking back at Heparin-Induced thrombocytopenia (HIT): What a physician should know? 2008 Treating MRSA: Update and Clinical Application of Vancomycin
Farooq Bandali Curriculum Vitae Page 7 2008 Shock Syndromes 2008 Managing Delirium in the Intensive Care Unit 2007 Striking back at Heparin-Induced thrombocytopenia (HIT): What a physician should know? 2006 Preventing Errors Related to Fluid and Electrolyte Management: The Role of the Pharmacist PEER-REVIEWED PUBLICATIONS Brunetti L, Bandali F. Dabigatran: is there a role for coagulation assays in guiding therapy? Ann Pharmacother. 2013 Jun;47(6):828-40 Thomas Z, Bandali FA, McCowen KC, Malhotra A. Drug-induced endocrine disorders in the Intensive Care Unit. Crit Care Med. 2010;38:S219-30 Bandali, FA and Thomas Z. Recombinant Factor VIIa in Intracerebral Hemorrhage. Hospital Pharmacy February 2008; 43 (2): 90-97. BOOK CHAPTER Thomas Z, Bandali F. Drug-Induced Endocrine Disorders. In: Papadopoulos J, Cooper B, Corbett SM, Kane-Gill S, eds. Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment. Mount Prospect, IL: Society of Critical Care Medicine; 2012 ABSTRACTS Bauer S, Thomas Z, Bandali F, Kane-Gill S, Voils S, Lat I. Growth of A Pharmacist-Led Critical Care Practice-Based Research Network: the Critical Care Pharmacotherapy Trials Network [abstr]. Crit Car Med 2012;40:A152S. Bandali F, Thomas Z, Sankaranarayanan J, Reardon T, Olsen K. Prevalence and Factors Associated With Prolonged Surgical Prophylaxis: Analysis From the Prolonged Empiric Antibiotic Therapy Study [abstr]. Crit Car Med 2011;39:A297S. Thomas Z, Bandali F, Sankaranarayanan J, Reardon T, Olsen K. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult Intensive Care Units in the United States [abstr]. Crit Car Med 2011;39:A291S. Barbarello-Andrews L, Bandali FA, Pfeiffer CM. Assessment of Outcomes of a Unique Critical Care Elective Course poster presentation at the 2009 Annual Meeting for the American Association of Colleges of Pharmacy in Boston, MA
Farooq Bandali Curriculum Vitae Page 8 CONTRIBUTOR FOR SCCM DRUG SHORTAGE TASK FORCE 2012 Drug Shortage Alert: Intravenous Sodium Bicarbonate http://www.learnicu.org/lists/web%20contents/attachments/9300/drugsh ortagesummary1_final%20%282%29.pdf ABSTRACT REVIEWER 2011 - Present Society of Critical Care Medicine Annual Congress ADVISORY BOARD 2012 Ikaria Therapeutics LLC 2009 ProEd Communications, Inc LEGAL CASE REVIEW 2013 Expert opinion provided for Birdsall & Laughlin, LLC 1720 Highway 34 Wall Township, New Jersey 07719 RESEARCH 2009-2011 Characterizing Antimicrobial Use in the Critically ill and Determination of the Prevalence of Prolonged Empiric Antibiotic Therapy co-primary investigator 2007 The Prevalence of Off-label Medication Use in Adult Critical Care in the United States. Sponsor: Society of Critical Care Medicine/Clinical Pharmacy and Pharmacology Network Site Investigator GRANTS 2011 Thermo Scientific Biomarkers: Awarded $5000 for an unrestricted medical education grant for the Continuing Education Program at Rutgers titled Clinical Pearls in Infectious Disease SERVICE National Organizations 2012-Present 2012-Present Appointed Member, SCCM Drug Shortage Task Force Member, Program Committee, SCCM Clinical Pharmacy and Pharmacology (CPP) Section
Farooq Bandali Curriculum Vitae Page 9 2012-Present 2011-Present Member, Communications Committee, SCCM CPP Section Member, Program Committee, American College of Clinical Pharmacy (ACCP) 2010 Chair, Research Committee, SCCM CPP Section 2009 Co-Chair Research Committee, SCCM CPP Section 2008 Member, SCCM, CPP Research Committee 2012-Present 2011-Present Rutgers, The State University Of New Jersey Rho Chi Advisor Member, Accreditation Council for Pharmacy Education (ACPE) Self-Study Mission, Planning and Evaluation Working Group Admissions and Recruitment Committee 2010-Present 2007 2010 Academic Integrity Committee 2007 Present Continuing Education (CE) Committee Programs Co-Coordinator for the Rutgers CE Committee 2012 Anticoagulants and Antiplatelets Getting To the Heart of the Matter 2012 Clinical Pearls in Infectious Disease 2011 Infectious Diseases in 2011: A Major Public Health Concern 2011 Therapeutic Updates: What Every Pharmacist Should Know 2009 Infection Disease CE Seminar 2008 Cardiology CE Seminar AFFILIATIONS/MEMBERSHIPS 2011-Present 2011-Present 2005-Present 2003-Present New Jersey Society of Health-System Pharmacist American Association of Colleges of Pharmacy Member, Society of Critical Care Medicine Member, American College of Clinical Pharmacy Member, American Society of Health-System Pharmacists HONORS AND AWARDS 2011 Presidential Citation, Society of Critical Care Medicine